US5801247A - Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof - Google Patents

Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof Download PDF

Info

Publication number
US5801247A
US5801247A US08/787,994 US78799497A US5801247A US 5801247 A US5801247 A US 5801247A US 78799497 A US78799497 A US 78799497A US 5801247 A US5801247 A US 5801247A
Authority
US
United States
Prior art keywords
group
phenyl
methyl
reacting
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/787,994
Inventor
David R. Dalton
Yifang Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Priority to US08/787,994 priority Critical patent/US5801247A/en
Assigned to TEMPLE, UNIVERSITY OF, COMMONWEALTH SYSTEM OF, THE HIGHER EDUCATION reassignment TEMPLE, UNIVERSITY OF, COMMONWEALTH SYSTEM OF, THE HIGHER EDUCATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HUANG, YIFANG, DALTON, DAVID R.
Priority to PCT/US1998/000941 priority patent/WO1999046243A1/en
Application granted granted Critical
Publication of US5801247A publication Critical patent/US5801247A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to azasugar compounds, and more particularly to the efficient synthesis thereof.
  • Carbohydrates are a large class of natural substances that structurally are polyhydroxycarbonyl compounds and their derivatives. Carbohydrates generally correspond to the formula (C) n (H 2 O) n where n is an integer usually greater than 3.
  • Monosaccharides are simple carbohydrates that cannot be further hydrolyzed into simpler types of carbohydrates.
  • a monosaccharide having a six-membered ring is referred to as a pyranose, whereas a five-membered ring monosaccharide is referred to as furanose.
  • a pyranose or furanose lacking one or more hydroxyl groups normally present in a carbohydrate is referred to as a deoxypyranose or deoxyfuranose, with the carbon chain position at which the hydroxy is absent being indicated.
  • Azasugars are a class of saccharides in which the ring oxygen is replaced by an imino group (--NH--).
  • a six-membered ring azasugar can be referred to as an azapyranose or a polyhydroxylated piperidine compound.
  • a five-membered ring azasugar can be referred to as an azafuranose or a polyhydroxylated pyrrolidine.
  • An azasugar can also be named as an aza derivative of an otherwise systematically or trivially named pyranose or furanose monosaccharide.
  • azasugars which are derived from piperidines (azapyranoses), can be hyrdroxylated at the 3-,4- and 5-positions, have hydrogen at the 6-position and can have a methyl group or hydrogen at the 2-position, the 1-position being the nitrogen atom, in piperidine nomenclature.
  • Dideoxyazapyranoses are the polyhydroxylated piperidines as discussed above, that have either a methyl group or hydrogen at the 5-position, hydrogen at the 1-position and can have hydroxyl groups elsewhere on the ring, as above, in pyranose nomenclature. Pyranose nomenclature and numbering will usually be used herein for six-membered ring compounds, unless otherwise specified.
  • azasugars described herein are derived from pyrrolidines (azafuranoses). These compounds can be hydroxylated at the 3- and 4-positions, have a hydroxymethyl group at the 5-position, and a methyl or hydroxymethyl at the 2-position, the 1-position being the nitrogen atom, in pyrrolidine nomenclature.
  • a 2-hydroxymethyl group in pyrrolidine nomenclature corresponds to a 2-hydroxymethyl or 4-hydroxymethyl group in furanose nomenclature.
  • Dihydroxyazafuranoses are the polyhydroxypyrrolidines discussed above that have an hydroxymethyl at the 4-position and a hydrogen at the 2-position or a hydrogen at the 4-position and an hydroxymethyl at the 2-position, and can have hydroxyl groups at the other positions, using furanose numbering. Pyrrolidine nomenclature and numbering will usually be used herein for these azasugars, unless otherwise specified.
  • the present invention relates to processes for the enantioselective synthesis of azasugars from amino acids.
  • An amino methyl ester is used as the starting material.
  • the ester is reacted with a benziminoethyl ether to produce an oxazoline or thiazoline.
  • L-serine methyl ester can be used to produce 4-(carbomethoxy)-2-phenyl-.increment.
  • 2 -oxazoline, or cysteine can be used to produce the corresponding thiazoline.
  • the oxazoline can be reduced to the aldehyde by treatment with a slight excess of DIBAL-H (diisobutylaluminum hydride).
  • the starting material for the present synthesis has the general form of compound 2.
  • the benziminoethyl ether 2a may be substituted on the benzene ring by any of various substituents. These substitutions will not affect the resulting azasugar, the substitutions will affect the intermediate products and their usefulness.
  • electron-donating hydrophobic groups may be substituted for R 1-3 .
  • R 1 , R 2 , and R 3 are preferably selected from the group consisting of H, C 1 -C 4 alkanes, and C 1 -C 4 ethers.
  • FT-IR Infrared
  • FT-IR Infrared
  • Solvents, reactive reagents, and column materials were purchased from Acros Chemical, Fisher Scientific, and/or Aldrich Chemical Companies. Solvents were distilled under argon prior to use. L- and D-serine were obtained from Acros Chemical Co., through Fisher Scientific, Pittsburgh, Pa. Optical rotations were taken as noted in a Perkin-Elmer 341 Polarimeter.
  • the isomeric alkenes were easily separated by column chromatography.
  • the total yield of the mixture of isomers, and their ratio can be varied by altering the conditions of the alcohol quench and the subsequent Wittig reaction.
  • the reaction mixture is quenched with t-butanol before carbomethoxymethylene triphenylphosphorane is added, 4 and 5 are produced in an overall yield of 83% and in a 1.5:1 ratio, respectively.
  • quenching the reaction with methanol but holding everything else the same provides a 72% yield of the mixture of 4 and 5 but now in a 1:8.5 ratio.
  • the diols 6 and 7 were separated and purified by silica gel flash column chromatography (eluting with 98:2 CH 3 Cl:CH 3 OH).
  • the alkene 4 was treated with (DHQ) 2 PHAL.
  • the alkene 4 (216 mg, 0.94 mmol), (DHQ) 2 PHAL (Aldrich, 7.3 mg, 9.4 ⁇ 10 -3 mmol), K 3 Fe(CN) 6 (823 mg, 2.84 mmol), potassium carbonate (387.3 mg, 2.8 mmol) and methansulfonamide (89 mg, 0.94 mmol) were dissolved in t-butanol (5.0 ml) and water (5.0 ml) at room temperature with stirring.
  • L-iminoarabinitol (2S,3S,4S)-3,4-dihydroxy-2-hydroxymethyl-pyrrolidine! was produced from lactam 8 as follows. Lactam 8 (252 mg, 1.0 mmol) in THF (5.0 ml) at 0° C. was treated with borane in THF (1.0M, 15 ml, 15 mmol) and the reaction, under an atmosphere of argon, brought to reflux and heated, with stirring, overnight. The solvent was removed at reduced pressure and methanol added to destroy unreacted borane. The methanol solution was treated with aqueous hydrogen chloride (6N, 1 ml), slowly added dropwise and, at room temperature, the solution was stirred for an additional 30 min.
  • aqueous hydrogen chloride (6N, 1 ml
  • Lactam 9 (58.4 mg, 0.23 mmol) in THF (6.0 ml) at 0° C. was treated with borane in THF (1.0M, 3.5 ml, 3.5 mmol, 15 equiv.) and the reaction, under an atmosphere of argon, brought to reflux and heated, with stirring, for 5 hours. The solvent was removed at reduced pressure and methanol added to destroy unreacted borane. The methanol solution was treated with aqueous hydrogen chloride (6N, 1 ml), slowly added dropwise and, at room temperature, the solution was stirred for an additional 30 min.
  • aqueous hydrogen chloride (6N, 1 ml)
  • alkene 5 (290 mg, 1.25 mmol),(DHQD) 2 PHAL (Aldrich, 9.8 mg, 12.5 ⁇ 10 -3 mmol), K 3 Fe(CN) 6 (1.24 g, 3.77 mmol), potassium carbonate (520 mg, 3.8 mmol) and methansulfonamide (89 mg, 0.94 mmol) were dissolved in t-butanol (5.0 ml) and water (5.0 ml) at room temperature with stirring.
  • L-iminoribitol was prepared as described above for L-iminoarabinatol and L-iminoxylitol (152 mg, 1.13 mmol, 86%) ⁇ !

Abstract

The present invention relates to processes for the enantioselective synthesis of hydroxypyrrolidines from amino acids. An amino methyl ester is used as the starting material. The ester is reacted with a benziminoethyl ether to produce an oxazoline or thiazoline. Specifically, L-serine methyl ester is used to produce 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline, and cysteine is used to produce the corresponding thiazoline. The oxazoline (or thiazoline) can be reduced to an aldehyde by treatment with a slight excess of DIBAL-H. The oxazoline is quenched with alcohol and reacted with (carbomethoxymethylene)triphenylphosphorane, to produce (S)-(+)-methyl (E)- and (S)-(-)-methyl (Z)-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate. The double bond is hydroxylated to yield the diol esters. The resulting diol is then treated with aqueous acid to hydrolyze the oxazoline and recyclize to produce 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate. This is treated with an excess of borane in tetrahydrofuran to yield (2-hydroxymethyl) 3,4-dihydroxypyrrolidine. The intermediate compounds are useful both in the present process and as final products themselves. The total yield of the mixture of isomers, as well as their ratio, can be varied.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to azasugar compounds, and more particularly to the efficient synthesis thereof.
2. Description of Related Art
Carbohydrates are a large class of natural substances that structurally are polyhydroxycarbonyl compounds and their derivatives. Carbohydrates generally correspond to the formula (C)n (H2 O)n where n is an integer usually greater than 3.
Monosaccharides are simple carbohydrates that cannot be further hydrolyzed into simpler types of carbohydrates. A monosaccharide having a six-membered ring is referred to as a pyranose, whereas a five-membered ring monosaccharide is referred to as furanose. A pyranose or furanose lacking one or more hydroxyl groups normally present in a carbohydrate is referred to as a deoxypyranose or deoxyfuranose, with the carbon chain position at which the hydroxy is absent being indicated.
Azasugars are a class of saccharides in which the ring oxygen is replaced by an imino group (--NH--). A six-membered ring azasugar can be referred to as an azapyranose or a polyhydroxylated piperidine compound. A five-membered ring azasugar can be referred to as an azafuranose or a polyhydroxylated pyrrolidine. An azasugar can also be named as an aza derivative of an otherwise systematically or trivially named pyranose or furanose monosaccharide.
One group of azasugars which are derived from piperidines (azapyranoses), can be hyrdroxylated at the 3-,4- and 5-positions, have hydrogen at the 6-position and can have a methyl group or hydrogen at the 2-position, the 1-position being the nitrogen atom, in piperidine nomenclature. Dideoxyazapyranoses are the polyhydroxylated piperidines as discussed above, that have either a methyl group or hydrogen at the 5-position, hydrogen at the 1-position and can have hydroxyl groups elsewhere on the ring, as above, in pyranose nomenclature. Pyranose nomenclature and numbering will usually be used herein for six-membered ring compounds, unless otherwise specified.
Another group of azasugars described herein are derived from pyrrolidines (azafuranoses). These compounds can be hydroxylated at the 3- and 4-positions, have a hydroxymethyl group at the 5-position, and a methyl or hydroxymethyl at the 2-position, the 1-position being the nitrogen atom, in pyrrolidine nomenclature. A 2-hydroxymethyl group in pyrrolidine nomenclature corresponds to a 2-hydroxymethyl or 4-hydroxymethyl group in furanose nomenclature. Dihydroxyazafuranoses are the polyhydroxypyrrolidines discussed above that have an hydroxymethyl at the 4-position and a hydrogen at the 2-position or a hydrogen at the 4-position and an hydroxymethyl at the 2-position, and can have hydroxyl groups at the other positions, using furanose numbering. Pyrrolidine nomenclature and numbering will usually be used herein for these azasugars, unless otherwise specified.
It is now clear that these carbohydrates mediate the related properties of cell-cell recognition (necessary for cellular aggregation and differentiation) and cell-cell fusion (necessary for the subsequent transmission of information). Glycosidases, intimately involved in those and related processes, have been shown to be inhibited by some of the members of the group of eight stereoisomeric 2-hydroxymethyl-3,4-dihydroxy-pyrrolidines, and related nitrogenous materials. It has even been suggested that these and other aminosugars could bind directly to viral or host-cell carbohydrate receptors to produce the results of their biological activity. As such, azasugars can be useful for treating metabolic disorders such as diabetes, as antiviral agents, as antimicrobial agents, or as anticancer agents. Exploration of their mode(s) of action has only begun.
Despite their clear usefulness, there is still a need for an effective synthesis of novel azasugars and their derivatives. Both carbohydrate and noncarbohydrate precursors have been employed in syntheses of the members of the pairs of enantiomers of imino -ribitol, -arabinitol, -xylitol, and -lyxitol. In general, the routes are complex and it is possible that this may have impeded exploration of their full potential.
SUMMARY OF THE INVENTION
The present invention relates to processes for the enantioselective synthesis of azasugars from amino acids. An amino methyl ester is used as the starting material. The ester is reacted with a benziminoethyl ether to produce an oxazoline or thiazoline. Specifically, L-serine methyl ester can be used to produce 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline, or cysteine can be used to produce the corresponding thiazoline. The oxazoline can be reduced to the aldehyde by treatment with a slight excess of DIBAL-H (diisobutylaluminum hydride). This is quenched with alcohol and reacted with (carbomethoxymethylene)triphenylphosphorane, to produce (S)-(+)-methyl (E)- and (S)-(-)- methyl (Z)-3-(4,5dihydro-2-phenyl-4-oxazolyl)-2-propenoate. The double bond is hydroxylated to yield the diol esters. The resulting diol is then treated with aqueous acid, whereby hydrolysis of the oxazoline and recyclization takes place resulting in the formation of 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate. This is treated with an excess of borane in tetrahydrofuran to give the resulting (2-hydroxymethyl) 3,4-dihydroxypyrrolidine. The intermediate compounds are useful both in the present process and as final products themselves. The total yield of the mixture of isomers, as well as their ratio, can be varied.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
As shown by reaction Scheme I, the starting material for the present synthesis has the general form of compound 2. The groups containing X1 and X2 can be in either position around the chiral center. Note that if X2 =H, no chiral center is present. Commonly, threonine methyl ester (X1 =O, X2 =CH3), serine methyl ester (X1 =O, X2 =H), and cysteine methyl ester (X1 =S, X2 =H) are used. Other C1 -C4 esters may also be used. (e.g. serine ethyl ester). The following will describe the specific reactions which occur when L-serine methyl ester is used.
L-serine methyl ester 2 can be reacted with benziminoethyl ether (2a, R1, R2, R3 =H) to form the known, readily available 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline 3. The benziminoethyl ether 2a may be substituted on the benzene ring by any of various substituents. These substitutions will not affect the resulting azasugar, the substitutions will affect the intermediate products and their usefulness. Generally, electron-donating hydrophobic groups may be substituted for R1-3. Specifically, R1, R2, and R3 are preferably selected from the group consisting of H, C1 -C4 alkanes, and C1 -C4 ethers.
Although the present invention will be described for L- isomer, results for the D-serine isomer are the same. Only the L-serine isomer has been shown here, but is should be understood that the D-serine can be substituted to yield the appropriate stereoisomer products. ##STR1##
It should be noted that, where applicable throughout these descriptions, satisfactory elementary analysis (Galbraith Laboratories, Knoxville, Tenn.) and/or high resolution mass spectrometric analysis (The Pennsylvania State University, University Park, Pa. or Drexel University, Philadelphia, Pa.) have been obtained for all new compounds. 1 H (300 MHz) and 13 C (75 MHz) NMR spectra were obtained on a GE QE-300 NMR spectrometer. Chemical shifts are reported in parts per million (PM), δ, from TMS=0.00 ppm. Infrared (FT-IR) spectra were taken as neat oils (for noncyrstalline materials) or as KBr pellets for crystalline samples on Mattson 4020, Nicolet 800, or Digilab FTS-40 spectrometers. Solvents, reactive reagents, and column materials were purchased from Acros Chemical, Fisher Scientific, and/or Aldrich Chemical Companies. Solvents were distilled under argon prior to use. L- and D-serine were obtained from Acros Chemical Co., through Fisher Scientific, Pittsburgh, Pa. Optical rotations were taken as noted in a Perkin-Elmer 341 Polarimeter.
L-serine methyl ester hydrochloride (25 g, 161 mmol) was then suspended in dry methylene chloride (350 ml) and triethyl amine (28 ml, 20.3 g, 200 mmol) added. When the dissolution of the amine hydrochloride was complete, benziminoethyl ether hydrochloride (29.8 g, 162 mmol) was added as one portion. The reaction mixture was heated at reflux on the steam bath for 4 h and then stirred at room temperature, under argon, overnight. The pink reaction mixture was extracted twice with saturated sodium bicarbonate and the combined aqueous extracts back washed twice with half its volume of methylene chloride. The combined methylene chloride extracts were washed with brine, dried over magnesium sulfate, filtered, and the solvent removed at reduced pressure. Flash chromatography on silica gel (eluted with 1:1 ether:petroleum ether) provided the oxazoline methyl ester in 80% yield (26.4 g, 128.8 mmol, α!20 D =+117.2°, c=0.053 in CHCl3). 1 H NMR (2 HCCl3) .increment.7.98-8.01 (m, 2H); 7.48-7.54 (m, 1H); 7.39-7.45 (m, 2H); 4.97 (dd, J=7.8, 10.5, 1H); 4.71 (dd, J=8.7, 8.1, 1H); 4.60 (dd, J=10.5, 8.7, 1H); 3.83 (s, 3H).
When the resulting 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline 3 is treated with a slight excess of Dibal-H at low temperature, reduction to the aldehyde occurs. As the aldehyde is labile, an alcohol quench of the reaction mixture is followed, in the same flask, by direct addition of carboalkoxymethylene triphenylphosphorane, as shown in Scheme II. ##STR2## In this reaction, R4 is selected from the group consisting of C1 -C4 alkanes. Selection of R4 should be made carefully as it will likely affect the ratio of cis and trans isomers formed. Where R4 =CH3, 3a is carbomethoxymethylene triphenylphosphorane, and Scheme II becomes Scheme IIa: ##STR3##
This results in the formation of a mixture of S-(+)-methyl (E)-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate, 4, ( α!20 D =+60.2°, c=0.018 in CHCl3), and the corresponding S-(-)-methyl (Z)-isomer 5, ( α!20 D =-49.5°, c=0.094 in CHCl3).
Experimentally, the oxazoline methyl ester 3 (26.5 g, 129 mmol) in dry toluene (800 ml) was cooled to -78° C. under an argon atmosphere and DIBAL-H (1.5M, 137 ml) was added slowly, keeping the temperature of the toluene solution below -70° C. throughout. After stirring at -78° C. for an additional 3 hours, methanol (100 ml) was added, again keeping the temperature below -70° C., to terminate the reaction and, 30 min later, carbomethoxymethylene triphenylphosphorane (48.5 g, 150 mmol) in methanol (300 ml) was added and the reaction solution allowed to warm to room temperature. After stirring overnight, the solution was diluted with diethyl ether (600 ml) and extracted (2×150 ml) with aqueous sodium hydroxide (15%), twice (2×150 ml) with saturated sodium bicarbonate, and twice (2×150 ml) with brine. The solvent mixture was removed at reduced pressure and the residue suspended in light petroleum ether (300 ml). The crystalline triphenylphosphine oxide was removed by filtration and the residue, after removal of the solvent, chromatographed on silica gel, eluting with 80:20 ether:petroleum ether. The mixture (72% of theory) was 64% 5 (19.0 g) and 8.4% 4 (2.5 g).
The isomeric alkenes were easily separated by column chromatography.
Interestingly, the total yield of the mixture of isomers, and their ratio can be varied by altering the conditions of the alcohol quench and the subsequent Wittig reaction. For example, if the reaction mixture is quenched with t-butanol before carbomethoxymethylene triphenylphosphorane is added, 4 and 5 are produced in an overall yield of 83% and in a 1.5:1 ratio, respectively. Alternatively, quenching the reaction with methanol but holding everything else the same, provides a 72% yield of the mixture of 4 and 5 but now in a 1:8.5 ratio.
For the E isomer, 4, colorless oil, Rf 0.17, silica gel, 20:80 diethyl ether :petroleum ether, α!20 D =+60.2°, c=0.018 in CHCl3. 1 H (2 HCCl3) .increment.7.96-8.00 (m, 2H); 7.49-7.54 (m, 1H); 7.40-7.46 (m, 2H); 7.00 (dd, J=6.3, 15.6, 1H); 6.11 (dd, J=1.5, 15.6, 1H); 4.95-5.03 (m, 1H); 4.62 (dd, J=9.9, 10.2, 1H); 4.20 (dd, J=8.1, 8.4, 1H); 3.75 (s, 3H). 13 C NMR (2 HCCl3) .increment.166.58, 165.33, 146.67, 131.75, 128.39, 127.12, 122.14, 71.72, 66.74, 51.68. IR (neat film, cm-1) 1722.2, 1650.9, 1603.1, 1580.0, 1495.6, 1450.3, 1359.6, 1280.5, 1192,8, 1082.4, 1025.5, 974.4, 923.7, 864.9, 781.5, 756.0, 696.7. HRMS calcd for C13 H13 NO3 231.0895: Found M!+ 231.0888.
For the Z isomer, 5, colorless oil, Rf 0.39, silica gel, 20:80 diethyl ether: petroleum ether, α!20 D =-49.5°, c=0.094 in CHCl3. 1 H NMR (2 HCCl3) .increment.7.96-7.99 (m, 2H); 7.48-7.52 (m, 1H); 7.40-7.46 (m, 2H); 6.44 (dd, J=7.2, 11.1, 1H); 5.92 (dd, J=11.4, 1.8, 1H); 5.71-5.80 (m, 1H); 4.87 (dd, J=9.9, 10.5, 1H); 4.10 (dd, J =8.4, 8.7, 1H); 3.76 (s, 3H). 13 C NMR (2 HCCl3) .increment.166.17, 165.29, 151.10, 131.50, 128.31, 127.52, 120.03, 73.38, 65.15, 51.44. IR (neat film, cm-1) 1717.9, 1651.4, 1603.1, 1580.0, 1496.1, 1449.8, 1396.3, 1356.3, 1204.9, 1084.3, 1026.0, 965.2, 896.3, 819.6, 780.5, 696.2. HRMS calcd for C13 H13 NO3 231.0895: Found M!+ 231.0888.
Where R-(-)-methyl (E)-3-(4,5dihydro-2-phenyloxazolyl)-2-propenoate (ent4) and R-(+)-methyl (Z)-3-(4,5 dihydro-2-phenyl-4-oxazolyl)-2-propenoate (ent-5) are prepared from D-serine using the same methods as described above with respect to production of 4 and 5 from the L-isomer of serine, ent4 has α!20 D =-51.5°, c=0.010 in CHCl3. HRMS calculated for C13 H13 NO3 2231.0895: Found M!+ 231.0884. For ent-5, α!20 D =+47.7°, c=0.013 in CHCl3. HRMS calculated for C13 H13 NO3 2231.0895: Found M!+ 231.0894.
As shown in Scheme III, treatment of the (E)-isomer, 4, in aqueous acetone with a catalytic amount of osmium tetroxide and the N-oxide of N-methylmorpholine (NMO) at room temperature yields (71%) a mixture of the diol esters 6 (2R,3S,4S; α!20 D =-1.2°, c=0.006 in CH3 OH) and 7 (2S,3R,4S; α!20 D =+73.9°, c=0.009 in CH3 OH) in a 1.6:1 ratio. The diasteromers are readily separated by column chromatography. This was performed with R4 =CH3. Other selections for R4 should be made carefully as they may affect the outcome of the reaction. ##STR4##
Several attempts to induce preferential formation of one of the diasteromers through stereoselective oxidation of 4 with the quinine derived, commercially available (DHQ)2 PHAL reagent in the presence of osmium tetroxide produced, in the best case, 65% of 6 and less than 5% of 7. Interestingly, results anticipated with the related (DHQD)2 PHAL reagent were not observed and improvement (both yield and stereochemical outcome) over NMO/OsO4 was not achieved. Other conventional methods of hydroxylation may also be used to achieve the same result.
Where R4 is CH3, the hydroxylation reaction occurs as shown in Scheme IIIa: ##STR5##
Experimentally, the E-alkene 4 (2.14 g, 9.3 mmol) in acetone (40 ml) and water (10 ml) was treated with N-methylmorpholine N-oxide (NMO) monohydrate (1.63 g, 12.0 mmol) and osmium tetroxide (1.0 ml of a 4% aqueous solution). Stirring was continued for 36 h at room temperature and the reaction was terminated by adding a saturated sodium bisulfite solution (5.0 ml) and stirring the resulting reaction mixture for an additional 30 min. The products were isolated by extracting the aqueous solution with an equal volume of ethyl acetate in three portions, combining the resulting solutions of organic solvents, drying them over sodium sulfate, filtering, and removing the solvent at reduced pressure.
The diols 6 and 7 were separated and purified by silica gel flash column chromatography (eluting with 98:2 CH3 Cl:CH3 OH).
Diol 6, mp 183° C., from ethanol, 1.06 g, 4 mmol, 43%, α!20 D =-1.2°, c =0.006 in CH3 OH. 1 H NMR (C2 H3 O2 H): 7.91-7.95 (m, 2H), 7.50-7.56 (m, 1H), 7.14-7.47 (m, 2H), 4.44-4.63 (m, 4H), 4.00 (dd, J=5.7, 2.1, 1H), 3.76 (s, 3H); 13 C NMR (C2 H3 O2 H): 173.4, 165.7, 131.5, 128.1, 128.0, 127.1, 73.7, 72.1, 69.5, 67.8, 51.1; IR (KBr pellet, cm-1 3330.8, 1748.4, 1643.2, 1449.4, 1363.6, 1274.9, 1218.9, 1142.7, 1104.2, 736.8, 694.3; HRMS calculated for C13 H15 NO5 +H! 266.1028478: Found: M+H!+ 266.103644. Anal. Calculated for C13 H15 NO5 C, 58.86 H, 5.70 N, 5.28. Found: C, 58.96 H, 5.87 N, 5.21.
Diol 7, mp 106° C., 668.5 mg, 2.5 mmol, 27%, α!20 D =+73.9°, c=0.009 in CH3 OH. 1 H NMR (C2 H3 O2 H): 7.91-7.95 (m, 2H), 7.50-7.56 (m, 1H), 7.14-7.47 (m, 2H), 4.48-4.56 (m, 3H), 4.34 (d, J=3.0, 1H), 3.99 (dd, J=5.1, 3.0, 1H), 3.76 (s, 3H); 13 C NMR (C2 H3 O2 H): 173.1, 165.7, 131.5, 128.1, 128.0, 127.1, 73.1, 71.9, 69.3, 68.6, 51.2; IR (KBr pellet, cm-1) 3356.9, 1732.9, 1656.8, 1449.4, 1359.7, 1244.0, 1139.8, 1093.6, 1045.3, 967.2, 808.1, 770.5, 694.3; HRMS calculated for C13 H15 NO5 +H! 266.1028478: Found: M+H!+ 266.103622. Anal. Calculated for C13 H15 NO5 C, 58.86 H, 5.70 N, 5.28. Found: C, 58.86 H, 5.78 N, 5.07.
To determine the effect of other methods of dihydroxylation, the alkene 4 was treated with (DHQ)2 PHAL. The alkene 4 (216 mg, 0.94 mmol), (DHQ)2 PHAL (Aldrich, 7.3 mg, 9.4×10-3 mmol), K3 Fe(CN)6 (823 mg, 2.84 mmol), potassium carbonate (387.3 mg, 2.8 mmol) and methansulfonamide (89 mg, 0.94 mmol) were dissolved in t-butanol (5.0 ml) and water (5.0 ml) at room temperature with stirring. With stirring, osmium tetroxide (4% in water, 70 ml) was added and stirring was continued at room temperature for 48 h before saturated sodium bisulfite solution was added to quench the reaction. After stirring for an additional 20 min, the aqueous solution was extracted with three times its volume of ethyl acetate in three portions. The combined organic extracts were dried over sodium sulfate, filtered and the solvent evaporated. The diols 6 (166 mg, 0.63 mmol, 67%) and 7 (11 mg, 0.04 mmol, 4.5%) ratio 15:1 were separated and purified by silica gel flash column chromatography by elution with 98:2 CHCl3 :CH3 OH.
When the diol 6 is treated with aqueous acid, hydrolysis of the oxazoline and recyclization to the 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate (R4 =CH3) ( α!20 D =-47.6°, c=0.006 in CH3 OH) (3R,4S,5S)-8 occurs in 61% yield. The structure of 8 is confirmed by x-ray crystallography. The diasteromer of 6, the diol 7, produces the corresponding ester ( α!20 D =-110°, c=0.006 in CH3 OH) (3S,4R,5S)-9 under the same conditions in 60% isolated yield. This reaction is shown in Scheme IV. ##STR6##
Experimentally, preparation of the lactam 8 from the diol 6 was as follows. With stirring, the diol 6 (2.646 g, 99.4 mmol) in THF (100 ml) was treated with aqueous hydrochloric acid solution (1.5M, 20 ml). After 24 hrs at room temperature, the reaction mixture was neutralized by addition of solid sodium bicarbonate, the solvent removed at reduced pressure, and the product isolated and purified from the residue by flash column chromatography over silica gel. The elution was begun with 10:90 CH3 OH:CHCl3 mixture and this was followed by a mixture of 60:20:10:10 CH2 Cl2 :CH3 CH2 OH:CH3 OH:NH4 OH. Lactam 8, a white solid (1.5148 g, 60.4%, mp 138° C. was recrystallized in acetone/chloroform. Rf=0.17 in 10:90 CH3 OH:CHCl3, α!20 D =-47.6° (c=0.006, methanol). 1 H NMR (C2 H3 O2 H): 8.04-8.08 (m, 2H), 7.58-7.63 (m, 1H), 7.44-7.49 (m, 2H), 4.60 (dd, J=11.7, 3.0, 1H), 4.32 (dd, J=12.0, 5.4, 1H), 4.17 (d, J=7.5, 1H), 4.05 (dd, J=7.2, 7.5, 1H), 3.63 (ddd, J=7.2, 5.4, 3.0, 1H); 13 C NMR (C2 H3 O2 H): 175.0, 166.3, 133.0, 129.5, 129.1, 128.2, 75.8, 75.5, 63.4, 56.3; IR (KBr pellet, cm-1) 3369.4, 3289.4, 1672.1, 1600.8, 1453.8, 1384.8, 1323.1, 1280.6, 1129.2, 1102.2, 891.0, 707.8, 630.6; HRMS calcd for C12 H13 NO5 +H! 252.0871978: Found: M+H!+ 252.087132. Anal. Calcd for C12 H13 NO5 C, 57.37 H, 5.22 N, 5.58. Found: C, 57.19 H, 5.43 N, 5.50.
Experimentally, preparation of the lactam 9 from the diol 7 was as follows. The diol 7 (95.2 mg, 0.36 mmol) was dissolved in methanol (3 ml) at room temperature and aqueous 1N HCl (1.0 ml) added. The resulting solution was permitted to stir at room temperature for 20 h and then neutralized by addition of solid sodium bicarbonate. The solvent was evaporated and the product was isolated and purified by flash column chromatography over silica gel, initially eluted with 10:90 CH3 OH:CHCl3 and then a 60:20:10:10 mixture of CH2 Cl2 :CH3 CH2 OH:CH3 OH:NH4 OH. Lactam 9, a white solid (0.0598 g, 66.1%, mp 192° C., was recrystallized in ethanol, Rf=0.15 (CH3 OH(10)/CHCl3 (90), α!20 D =-110° (c=0.006, methanol). 1 H NMR (C2 H3 O2 H): 8.00-8.04 (m, 2H), 7.58-7.63 (m, 1H), 7.46-7.50 (m, 2H), 4.54 (dd, J=11.7, 3.3, 1H), 4.33 (dd, J=11.7, 4.8, 1H), 4.38 (dd, J=7.5, 8.1, 1H), 4.29 (d, J=8.1, 1H), 3.93 (ddd, J=7.5, 4.8, 3.3, 1H); 13 C NMR (C2 H3 O2 H): 175.0, 166.2, 133.0, 129.3, 129.0, 128.2, 74.5, 74.2, 63.0, 54.4; IR (KBr pellet, cm-1) 3408.9, 3209.4, 1722.3, 1665.4, 1600.6, 1434.0, 1377.1, 1317.3, 1264.2, 1124.4, 1089.7, 1019.3, 920.0, 787.6, 707.8; HRMS calcd for C12 H13 NO5 +H! 252.0871978: Found: M+H!+ 252.087232. Anal. Calcd for C12 H13 NO5 C, 57.37 H,5.22 N, 5.58. Found: C, 57.32 H, 5.30 N, 5.40
Then, the lactam-ester 8 with an excess of borane in tetrahydrofuran, cleanly undergoes reduction of both carbonyl functionalities simultaneously and quantitatively to yield the known L-iminoarabinitol (2S,3S,4S)-3,4-dihydroxy-2-hydroxymethyl-pyrrolidine!, 1, ( α!20 D =11.9°, c=0.044 in CH3 OH; with the corresponding hydrochloride salt, α!20 D =28.8°, c=0.049 in H2 O; for the enantiomer α!20 D =+7.8°, c=0.46 in H2 O and for the enantiomeric hydrochloride salt, α!20 D =+37.9°, c=0.53 in H2 O).
Experimentally, L-iminoarabinitol (2S,3S,4S)-3,4-dihydroxy-2-hydroxymethyl-pyrrolidine! was produced from lactam 8 as follows. Lactam 8 (252 mg, 1.0 mmol) in THF (5.0 ml) at 0° C. was treated with borane in THF (1.0M, 15 ml, 15 mmol) and the reaction, under an atmosphere of argon, brought to reflux and heated, with stirring, overnight. The solvent was removed at reduced pressure and methanol added to destroy unreacted borane. The methanol solution was treated with aqueous hydrogen chloride (6N, 1 ml), slowly added dropwise and, at room temperature, the solution was stirred for an additional 30 min. Then, solid sodium hydroxide was added until the solution was basic and the product directly isolated (133 mg, 96% of theory) by aqueous solution ion-exchange chromatography on DOWEX 50WX8-100 and a final flash-chromatographic purification over a short silica gel column where it eluted with a 50:20:20:10 mixture of CH2 Cl2 :CH3 CH2 OH:CH3 OH:NH4 OH to yield material with ( α!20 D =-11.9°, c=0.044 in CH3 OH; for the enantiomer α!20 D =+7.8°, c=0.46 in H2 O). 1 H NMR (C2 H3 O2 H): 4.06 (ddd, J=5.7, 3.9, 3.9, 1H), 3.77 (dd, J=3.9, 3.9, 1H), 3.67 (dd, J=11.4, 4.8, 1H), 3.58 (dd, J=11.7, 6.6, 1H), 3.25 (s, N-H), 3.08 (dd, J=12.3, 5.7, 1H), 2.97 (ddd, J=6.6, 4.8, 3.9,1H), 2.80 (dd, J=12.3, 3.9, 1H); 13 C NMR (C2 H3 O2 H): 78.5, 77.0, 65.3, 61.5, 50.4; IR (neat film, cm-1) 3423, 1645.2, 1530.4, 1422.4, 1206.4, 1115.7; HRMS calcd for C5 H11 NO3 +H! 134.0817184: Found: M+H!+ 134.081568: Found M+H!+ 134.081568. The hydrochloride, obtained on treatment of the free base with 6N HCl and recrystallized from methanol/acetone had α!20 D =-28.8°, c=0.049 in H2 O (lit for the enantiomeric hydrochloride salt, α!20 D =+37.9°, c=0.53 in H2 O); 1 H NMR (2 H2 O): 4.26 (ddd, J =4.5, 3.3, 2.4, 1H), 4.02 (dd, J=3.6, 3.3, 1H), 3.88 (dd, J=12.0, 5.7, 1H), 3.76 (dd, J=12.3, 8.1, 1H), 3.55 (ddd, J=8.1, 5.7, 3.9, 1H), 3.51 (dd, J=12.6, 4.5, 1H), 3.29 (dd, J=12.6, 2.4, 1H); 13 C NMR (2 H2 O): 75.7, 74.3, 66.5, 58.9, 50.0; IR (KBr pellet, cm-1) 3352, 1625.9, 1112.8, 1059.4, 1019.3.
A diasteromer of L-iminoarabinitol, the known L-iminoxylitol (2S,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine!, 1, ( α!20 D =-4.4°, c=0.010 in CH3 OH; for the corresponding hydrochloride salt, α!20 D =-8.6°, c=0.010 in H2 O; lit α!22 D =-1.3°, c=0.540 in H2 O) is obtained in 91% yield from 9 in the same way.
Experimentally, the following protocol was used. Lactam 9 (58.4 mg, 0.23 mmol) in THF (6.0 ml) at 0° C. was treated with borane in THF (1.0M, 3.5 ml, 3.5 mmol, 15 equiv.) and the reaction, under an atmosphere of argon, brought to reflux and heated, with stirring, for 5 hours. The solvent was removed at reduced pressure and methanol added to destroy unreacted borane. The methanol solution was treated with aqueous hydrogen chloride (6N, 1 ml), slowly added dropwise and, at room temperature, the solution was stirred for an additional 30 min. Then, solid sodium hydroxide was added until the solution was neutral and the product directly isolated (21.8 mg, 91% of theory) by ion-exchange chromatography on DOWEX 50WX8-100 and a final flash-chromatographic purification over a short silica gel column where it eluted with a 50:20:20:10 mixture of CH2 Cl2 :CH3 CH2 OH:CH3 OH:NH4 OH to yield material with α!20 D =-4.4°, c=0.010 in CH3 OH. 1 H NMR (C2 H3 O2 H): 4.13 (m, 1H), 4.07 (m, 1H), 3.75 (dd, J=11.4, 6.3, 1H), 3.63 (dd, J=11.4, 67.2, 1H), 3.35 (m, 1H), 3.28 (dd, J=12.9, 5.1, 1H), 2.78 (dd, J=12.9, 1.8, 1H); 13 C NMR (C2 H3 O2 H): 75.9, 75.6, 61.7, 58.8, 50.6; IR (neat film, cm-1) 3380, 1654.8, 1420.5, 1048.2; HRMS calcd for C5 H11 NO3 +H! 134.0817184: Found: M+H!+ 134.081675. The hydrochloride, obtained on treatment of the free base with 6N HCl and recrystallized from methanol/acetone had α!20 D =-8.6°, c=0.010 in H2 O; 1 H NMR (2 H2 O): 4.32 (d, br, J =3.3, 1H), 4.25 (s, br, 1H), 3.95 (dd, J=15.3, 8.7, 1H), 3.83 (m, 2H), 3.60 (dd, J=12.9, 4.2, 1H), 3.23 (d, br, J=12.9, 1H); 13 C NMR (H2 O): 74.3, 74.2, 63.0, 57.2, 50.5. IR (KBr pellet, cm-1) 3383, 1625.9, 1412.8, 1308.6, 1101.3, 1047.3, 978.8, 913.2.
Both reactions are shown in Scheme V. ##STR7##
In direct compliment to the above sequence of reactions, hydroxylation of the (Z)-isomer 5 (as by treatment of with osmium tetroxide) as shown in Scheme VI produces a mixture of the diol esters 11 (2R,3R,4S; α!20 D =+48.3°, c=0.009 in CH3 OH) and 10 (2S,3S,4S; α!20 D =+51.8°, c=0.007 in CH3 OH) in a 3.2:1 ratio (73% overall). As before, these isomers are readily separated by column chromatography. ##STR8##
Experimental production of the diols 10 and 11 was as follows. The Z-alkene 5 (10.67 g, 46.2 mmol) in acetone (80 ml) and water (10 ml) was treated with N-methylmorpholine N-oxide (NMO) monohydrate (9.35 g, 69.2 mmol) and osmium tetroxide (6.8 ml of a 4% aqueous solution). Stirring was continued for 16 h at 0° C. and the reaction was terminated by adding a saturated sodium bisulfite solution (10.0 ml) and stirring the resulting reaction mixture for an additional 30 min. The products were isolated by extracting the aqueous solution with an equal volume of ethyl acetate in four portions, combining the resulting solutions of organic solvents, drying them over sodium sulfate, filtering, and removing the solvent at reduced pressure. Diols 10 and 11 were separated and purified by flash chromatography (eluting with 98.5:1.5 CH3 Cl:CH3 OH).
Diol 11, mp 159° C., 6.79 g, 25.6 mmol, 55.5%, α!20 D =+48.3°, c=0.009 in CH3 OH. 1 H NMR (C2 H3 O2 H): 7.89-7.93 (m, 2H), 7.50-7.56 (m, 1H), 7.40-7.45 (m, 2H), 4.44-4.60 (m, 3H), 4.28 (d, J=4.8, 1H), 4.05 (dd, J=4.2, 4.2, 1H), 3.75 (s, 3H); 13 C NMR (C2 H3 O2 H): 172.9, 165.5, 131.4, 128.0, 127.9, 127.2, 73.7, 73.1, 68.6, 67.1, 51.0; IR (KBr pellet, cm-1) 3444.6, 1736.8, 1644.2, 1450.4, 1370.3, 1296.0, 1238.2, 1109.0, 989.4, 949.9, 730.9, 694.3; HRMS calcd for C13 H15 NO5 +H! 266.1028478: Found: M+H!+ 266.103391: Anal. Calcd for C13 H15 NO5 C, 58.86 H, 5.70 N, 5.28. Found: C, 59.33 H, 5.86 N, 5.20.
Diol 10, mp 157° C., 2.15 g, 8.1 mmol 17.5%, α!20 D =+51.8°, c=0.007 in CH3 OH. 1 H NMR (C2 H3 O2 H): 7.93-7.97 (m, 2H), 7.50-7.55 (m, 1H), 7.40-7.45 (m, 2H), 4.50-4.66 (m, 3H), 4.42 (dd, J=7.8, 7.8, 1H), 3.75 (s, 3H); 13 C NMR (C2 H3 O2 H): 173.8, 165.8, 131.3, 128.1, 128.0, 127.3, 73.0, 72.4, 69.2, 66.9, 51.0; IR (KBr pellet, cm-1) 3393.5, 1710.7, 1640.4, 1449.4, 1373.2, 1238.2, 1063.6, 1034.7, 954.7, 687.5; HRMS calcd for C13 H15 NO5 +H! 266.1028478: Found: M+H!+ 266.102911: Anal. Calcd for C13 H15 NO5 C, 58.86 H, 5.70 N, 5.28. Found: C, 59.25 H, 5.80 N, 5.22.
Here too, several attempts to induce preferential formation of one of the diasteromers through stereoselective dihydroxylation met with limited success. The alkene 5 (290 mg, 1.25 mmol),(DHQD)2 PHAL (Aldrich, 9.8 mg, 12.5×10-3 mmol), K3 Fe(CN)6 (1.24 g, 3.77 mmol), potassium carbonate (520 mg, 3.8 mmol) and methansulfonamide (89 mg, 0.94 mmol) were dissolved in t-butanol (5.0 ml) and water (5.0 ml) at room temperature with stirring. With stirring, osmium tetroxide (4% in water, 74 ml) was added and stirring was continued at 0° C. for 18 h before saturated sodium bisulfite solution was added to quench the reaction. After stirring for an additional 20 min, the aqueous solution was extracted with three times its volume of ethyl acetate in three portions. The combined organic extracts were dried over sodium sulfate, filtered and the solvent evaporated. The diol 11 (281 mg, 1.06 mmol, 84.8%) was purified by silica gel flash column chromatography by elution with 98:2 CHCl3 :CH3 OH. Thus, treatment of 5 with (DHQD)2 PHAL yields 85% of the isomer 11. However, use of (DHQ)2 PHAL produced only 17% of 10 and 64% of 11.
As shown in Scheme VII, on treatment of the diol 10 with aqueous acid, hydrolysis and recyclization to the 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate (3S,4S,5S)-12 occurs in 98% yield. Lactam 12 (3.16 g, 126 mmol, 98% of theory) was obtained from diol 10 (3.40 g, 128 mmol) by the same procedure used in the preparation of lactam 9 from diol 7 above. The product was recrystallized from methanol/diethyl ether with difficulty because of its limited solubility. Optical rotation was not taken because of its limited solubility.
For 12, mp 212° C., 1 H NMR (C2 H3 O2 H): 8.00-8.05 (m, 2H), 7.58-7.65 (m, 1H), 7.40-7.52 (m, 2H), 4.47 (dd, J=11.4, 4.5, 11H), 4.35 (dd, J=11.4, 5.1, 1H), 4.33 (d, J=5.7, 1H), 4.27 (dd, J=5.7, 1.5, 1H), 3.80 (ddd, J=5.1, 4.5, 1.5, 1H); 13 C NMR (C2 H3 O2 H): 176.5, 166.0, 133.0, 129.4, 129.1, 128.3, 70.0, 69.9, 64.2, 59.0; IR (KBr pellet, cm-1) 3242.1, 1719.4, 1690.5, 1438.6, 1264.2, 1146.6, 1102.2, 767.6, 706.8; HRMS calcd for C12 H13 NO5 +H! 252.0871978: Found: M+H!+ 252.087255: Anal. Calcd for C12 H13 NO5 C, 57.37 H, 5.22 N, 5.58. Found: C, 57.07 H, 5.38 N, 5.59.
The diasteromeric diol 11 produces the corresponding ester ( α!20 D =-35.9°, c=0.005 in CH3 OH) (3R,4R,5S)-13 in 97% isolated yield under the same conditions.
Lactam 13, a white solid (20.0 mg, 0.08 mmol) was obtained from diol 11 (21.8 mg, 0.08 mmol, 98%) by the same procedure which was used in the preparation of lactam 9. It was recrystallized in acetone/hexanes. Rf=0.20 in 10:90 CH3 OH:CHCl3. For 13, mp 145° C., α!20 D =-35.9° (c=0.005, methanol), 1 H NMR (C2 H3 O2 H): 8.06-8.09 (m, 2H), 7.58-7.63 (m, 1H), 7.45-7.51 (m, 2H), 4.60 (dd, J=11.4, 5.1, 1H), 4.43 (dd, J=5.4, 3.6, 1H), 4.40 (dd, J=11.1, 7.8, 1H), 4.27 (d, J=5.1, 1H), 3.95 (ddd, J=7.8, 5.1, 3.6, 1H); 13 C NMR (C2 H3 O2 H): 176.7, 166.4, 132.9, 129.7, 129.3, 128.1, 71.3, 69.1, 63.8, 54.4; IR (KBr pellet film, cm-1) 3365.5, 1706.9, 1448.4, 1281.6, 1162.4, 1120.5, 712.5; HRMS calcd for C12 H13 NO5 +H! 252.0871978: Found: M+H!+ 252.087147; Anal. Calcd for C12 H13 NO5 C, 57.37 H, 5.22 N, 5.58. Found: C, 56.31 H, 5.31 N. 5.38. ##STR9##
The reduction of the lactams 12 and 13 with removal of the benzoate is shown in Scheme VIII ##STR10##
Reduction of the lactam 12 and removal of the benzoate is accomplished with borane in THF in 86% yield to produce L-iminoribitol (2S,3S,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine!, 1, ( α!20 D =-30.5, c=0.039 in CH3 OH; and for the corresponding hydrochloride salt α!20 D =-62.3, c=0.006 in 2 O, lit=-59.0, c=0.59 in H2 O). L-iminoribitol was prepared as described above for L-iminoarabinatol and L-iminoxylitol (152 mg, 1.13 mmol, 86%) α!20 D =-30.5°, c=0.039 in CH3 OH. 1 H NMR (C2 H3 O2 H): 4.06 (ddd, J=5.1, 5.1, 3.9, 1H), 3.79 (dd, J=6.9, 5.1, 1H), 3.66 (dd, J=11.7, 4.2, 1H), 3.54 (dd, J=11.7, 6.0, 1H), 3.26 (s, N-H), 3.09 (dd, J=12.3, 5.1, 1H), 3.00 (ddd, J=6.9, 6.0, 4.2, 1H), 2.75 (dd, J=12.3, 3.9, 1H); 13 C NMR (C2 H3 O2 H): 73.0, 71.1, 62.3, 61.8, 49.9; IR (neat film, cm-1) 3380, 1651.9, 1532.3, 1426.2, 1346.2, 1103.2; HRMS calcd for C5 H11 NO3 +H! 134.0817184: Found: M+H!+ 134.081789.
The hydrochloride salt, obtained with 6N HCl in ethanol had α!20 D =-62.3°, c=0.006 in H2 O. 1 H NMR (2 H2 O): 4.31 (ddd, J=3.9, 3.9, 1.8, 1H), 4.13 (dd, J=8.7, 3.9, 1H), 3.90 (dd, J=12.3, 3.3, 1H), 3.75 (dd, J=12.3, 6.0, 1H), 3.56 (ddd, J=8.7, 6.0, 3.3, 1H), 3.43 (dd, J=12.9, 3.9, 1H), 3.30 (dd, J=12.9, 1.8, 1H); 13 C NMR (2 H2 O): 71.1, 69.4, 61.7, 57.9, 49.5. IR (KBr pellet, cm-1) 3395, 163.5, 1418.5, 1339.4, 1141.8, 106.1, 1043.4.
Its diasteromer, the known L-iminolyxitol (2S,3R,4S)-3,4 dihydroxy-2-hydroxymethylpyrrolidine!, 1, ( α!20 D =-12.9°, c=0.039 in CH3 OH; for the hydrochloride salt, α!20 D =-13.2, c=0.014 in H2 O; lit α!20 D =17.2°, c=0.4 in H2 O) is obtained in 96% yield from 13 with the same reagents. As described above for L-iminoarabinatol, L-iminoxylitol, and L-iminoribitol (24.9 mg, 0.18 mmol, 96%, α!20 D =-12.9°, c=0.014 in CH3 OH. 1 H NMR (C2 H3 O2 H): 4.42 (ddd, J=7.5, 7.2, 3.9, 1H), 4.27 (dd, J=4.2, 3.9, 1H), 3.91(dd, J=12.0, 5.1, 1H), 3.81 (dd, J=12.0, 8.4, 1H), 3.66 (ddd, J=8.4, 5.1, 3.9, 1H), 3.45 (dd, J=12.0, 7.5, 1H), 3.12 (dd, J=12.0, 7.2, 1H); 13 C NMR (C2 H3 O2 H): 70.0, 69.8, 62.4, 57.7, 47.0; IR (neat film, cm-1) 3318.3, 1770.5, 1634.5, 1418.5, 1133.1; HRMS calcd for C5 H11 NO3 +H! 134.0817184: Found: M+H!+ 134.081579) was obtained from the lactam 13 (48.9 mg, 0.194 mmol).
The hydrochloride obtained with 6N HCl in ethanol had α!20 D =-13.2°, c =0.014 in H2 O. 1 H NMR (2 H2 O): 4.44 (ddd, J=8.2, 4.8, 3.9, 1H), 4.29 (dd, J=4.2, 3.9, 1H), 3.93 (dd, J=12.0, 4.8, 1H), 3.84 (dd, J=12.0, 8.2, 1H), 3.69 (ddd, J=8.2, 4.8, 4.2, 1H), 3.48 (dd, J=12.0, 7.5, 1H), 3.27 (s, N-H), 3.15 (dd, J=12.0, 7.5, 1H); 13 C NMR (2 H2 O): 70.0, 69.8, 62.5, 57.6, 47.0; IR (KBr pellet, cm-1) 3423.4, 1612.4, 1406.9, 1341.4, 1137.9, 1101.2, 1041.5.

Claims (12)

What is claimed:
1. A method of synthesizing an S-methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate comprising reacting a 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline with diisobutyl aluminum hydride and a carboalkoxymethylene triphenylphosphorane of the following formula: ##STR11## wherein R4 is selected from the group consisting of C1 -C4 alkyl groups.
2. The method of claim 1 wherein reacting the 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline and diisobutyl aluminum hydride and a carboalkoxymethylene triphenylphosphorane of formula 3a comprises:
adding diisobutyl aluminum hydride to the 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline to form an aldehyde;
quenching the aldehyde with an alcohol to form a mixture; and
adding to the mixture a carboalkoxymethylene triphenylphosphorane of formula 3a.
3. The method of claim 2 wherein R4 is methyl.
4. A method of synthesizing diol esters selected from the group consisting of the following formulas: ##STR12## wherein OX is selected from the group consisting of ##STR13## wherein R4 is CH3, R1, R2, and R3 are each selected from the group consisting of H, C1 -C4 alkyl and C1 -C4 alkoxy, X2 is H or CH3 when X1 is S, and X2 is CH3 when X1 is O,
comprising hydroxylating a methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate.
5. The method of claim 4 wherein hydroxylating the methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate comprises reacting the methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate and an N-oxide of N-methylmorpholine.
6. The method of claim 5 wherein reacting the methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate and the N-oxide of N-methylmorpholine comprises:
suspending the methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate in aqueous acetone; and
adding osmium tetroxide and the N-oxide of N-methylmorpholine to the methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate.
7. A method of synthesizing a 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate selected from the group consisting of the following formulas: ##STR14## comprising reacting a diol ester selected from the group consisting of the following formulas: ##STR15## wherein OX is selected from the group consisting of ##STR16## and wherein R4 is CH3, R1, R2 and R3 are each selected from the group consisting of H, C1 -C4 alkyl and C1 -C4 alkoxy, X2 is H or CH3 when X1 is S, and X2 is CH3 when X1 is O,
with hydrochloric acid.
8. The method of claim 7 wherein reacting a diol ester selected from the group consisting of formulas 6, 7, 10 and 11 and hydrochloric acid comprises:
suspending the selected diol ester in tetrahydrofuran (THF) to form a mixture;
adding hydrochloric acid to the mixture; and
adding sodium bicarbonate to the mixture to neutralize the mixture.
9. The method of claim 7 wherein reacting the diol ester selected from the group consisting of formulas 6, 7, 10 and 11 and hydrochloric acid comprises:
dissolving in methanol the diol ester selected from the group consisting of compounds of formulas 6, 7, 10 and 11 to form a mixture;
adding hydrochloric acid to the mixture; and
adding sodium bicarbonate to the mixture to neutralize the mixture.
10. A method of synthesizing a 3,4-dihydroxy-2-hydroxymethylpyrrolidine comprising reacting a 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate selected from the group consisting of the following formulas: ##STR17## with borane in tetrahydrofuran.
11. A method of synthesizing a 3,4-dihydroxy-2-hydroxymethylpyrrolidine comprising:
reacting a methyl ester of formula 2 with a benziminoethyl ether of formula 2a: ##STR18## wherein X1 is selected from the group consisting of O and S, X2 is selected from the group consisting of H and CH3 and R1, R2 and R3 are selected from the group consisting of H, C1 -C4 alkanes and C1 -C4 ethers to form a 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline;
reacting the 4-(carbomethoxy)-2-phenyl-.increment.2 -oxazoline with diisobutyl aluminum hydride and carboalkoxymethylene triphenylphosphorane of formula 3a: ##STR19## wherein R4 is selected from the group consisting of C1 -C4 alkanes;
to form an S-methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate;
reacting the S-methyl-3-(4,5-dihydro-2-phenyl-4-oxazolyl)-2-propenoate with an N-oxide of N-methylmorpholine to form diol esters selected from the group consisting of the following formulas: ##STR20## wherein OX is selected from the group consisting of ##STR21## reacting the diol esters selected from the group consisting of formulas 6, 7, 10 and 11 with hydrochloric acid to form 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate selected from the group consisting of the following formulas ##STR22## reacting the 3,4-dihydroxy-5-hydroxymethylpyrrolidone benzoate selected from the group consisting of compounds of formulas 8, 9, 12 and 13 with borane in tetrahydrofuran to form a 3,4-dihydroxy-2-hydroxymethyl-pyrrolidine.
12. The method of claim 11 wherein X1 is O, X2 is H, R1, R2 and R3 are H and R4 is methyl.
US08/787,994 1997-01-23 1997-01-23 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof Expired - Fee Related US5801247A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/787,994 US5801247A (en) 1997-01-23 1997-01-23 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof
PCT/US1998/000941 WO1999046243A1 (en) 1997-01-23 1998-03-12 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/787,994 US5801247A (en) 1997-01-23 1997-01-23 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof
PCT/US1998/000941 WO1999046243A1 (en) 1997-01-23 1998-03-12 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof

Publications (1)

Publication Number Publication Date
US5801247A true US5801247A (en) 1998-09-01

Family

ID=26793890

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/787,994 Expired - Fee Related US5801247A (en) 1997-01-23 1997-01-23 Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof

Country Status (2)

Country Link
US (1) US5801247A (en)
WO (1) WO1999046243A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518437B1 (en) * 2000-08-02 2003-02-11 Board Of Trustees Of Michigan State University Process and intermediate compounds for the preparation of pyrrolidines
US20100298538A1 (en) * 2007-11-19 2010-11-25 Bcn Péptides, S.A. Method for the stereoselective preparation of amino acid derivatives

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2446192A (en) * 1946-01-26 1948-08-03 Merck & Co Inc Preparation of threonine and derivatives thereof
US2530627A (en) * 1946-09-06 1950-11-21 Merck & Co Inc Production of n-acyl allothreonine esters
US2571940A (en) * 1946-01-26 1951-10-16 Merck & Co Inc Oxazolines
US2772281A (en) * 1954-12-23 1956-11-27 Merck & Co Inc Synthesis of 4-amino-3-isoxazolidone and its derivatives
US2846439A (en) * 1956-06-05 1958-08-05 Takeda Pharmaceutical Reaction of threonines with aryl nitriles in a steric inversion process
US3310571A (en) * 1965-06-21 1967-03-21 Thiokol Chemical Corp Method of preparing oxazolines
US4702864A (en) * 1985-09-27 1987-10-27 E. I. Du Pont De Nemours And Company Analogs of platelet activating factor
US4978759A (en) * 1985-07-03 1990-12-18 Sanofi, S.A. And Institut National De La Sante Et De La Recherche Medicale Process for the stereospecific synthesis of optically pure 4-amino-3-hydroxycarboxylic acid derivatives
US5104984A (en) * 1985-03-29 1992-04-14 Merck & Co., Inc. Enantioselective process for producing 1-beta-methyl carbapenem antibiotic intermediates
US5229523A (en) * 1991-05-30 1993-07-20 The Scripps Research Institute 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines
US5250704A (en) * 1992-04-27 1993-10-05 Warner-Lambert Company Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
US5276120A (en) * 1991-05-30 1994-01-04 The Scripps Research Institute Process for forming omega-deuxy-azasugars
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
US5300660A (en) * 1986-05-22 1994-04-05 Astra Lakemedel Aktiebolag Efficient stereoconservative synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and intermediates thereto
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
US5466809A (en) * 1991-11-06 1995-11-14 Toronto Research Chemicals, Inc. Process for the preparation of immunostimulating swainsonine analogs
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2446192A (en) * 1946-01-26 1948-08-03 Merck & Co Inc Preparation of threonine and derivatives thereof
US2571940A (en) * 1946-01-26 1951-10-16 Merck & Co Inc Oxazolines
US2530627A (en) * 1946-09-06 1950-11-21 Merck & Co Inc Production of n-acyl allothreonine esters
US2772281A (en) * 1954-12-23 1956-11-27 Merck & Co Inc Synthesis of 4-amino-3-isoxazolidone and its derivatives
US2846439A (en) * 1956-06-05 1958-08-05 Takeda Pharmaceutical Reaction of threonines with aryl nitriles in a steric inversion process
US3310571A (en) * 1965-06-21 1967-03-21 Thiokol Chemical Corp Method of preparing oxazolines
US5104984A (en) * 1985-03-29 1992-04-14 Merck & Co., Inc. Enantioselective process for producing 1-beta-methyl carbapenem antibiotic intermediates
US4978759A (en) * 1985-07-03 1990-12-18 Sanofi, S.A. And Institut National De La Sante Et De La Recherche Medicale Process for the stereospecific synthesis of optically pure 4-amino-3-hydroxycarboxylic acid derivatives
US4702864A (en) * 1985-09-27 1987-10-27 E. I. Du Pont De Nemours And Company Analogs of platelet activating factor
US5300660A (en) * 1986-05-22 1994-04-05 Astra Lakemedel Aktiebolag Efficient stereoconservative synthesis of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines and intermediates thereto
US5468876A (en) * 1986-05-22 1995-11-21 Aktiebolaget Astra Intermediates for the stereoconservative synthesis of 1-substituted (S)-and (R)-2-aminomethylpyrrolidines
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
US5461143A (en) * 1991-03-18 1995-10-24 The Scripps Research Institute Oligosaccharide enzyme substrates and inhibitors: methods and compositions
US5229523A (en) * 1991-05-30 1993-07-20 The Scripps Research Institute 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines
US5276120A (en) * 1991-05-30 1994-01-04 The Scripps Research Institute Process for forming omega-deuxy-azasugars
US5352591A (en) * 1991-05-30 1994-10-04 The Scripps Research Institute Aldolase enzyme process for making 5-azido-5-deoxy-hexulose-1-phosphate
US5466809A (en) * 1991-11-06 1995-11-14 Toronto Research Chemicals, Inc. Process for the preparation of immunostimulating swainsonine analogs
US5250704A (en) * 1992-04-27 1993-10-05 Warner-Lambert Company Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
US5525735A (en) * 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds

Non-Patent Citations (36)

* Cited by examiner, † Cited by third party
Title
Chikashita et al., Chemical Abstracts, 114:23841 (1991). *
Corey et al., Tetrahedron Lett., 34(44), 6969 6972, 1993. *
Corey et al., Tetrahedron Lett., 34(44), 6969-6972, 1993.
Eggleton et al., Chemical Abstracts, 101:54975u (1984). *
Elliott, J. Chem. Soc., 589 (1949). *
Elliott, J. Chem. Soc., 62 (1950). *
Fronza, G., et al., "On the Use of (4S, 5S)-2-Phenyl-4, 5-Dimethyl-4-Formyl-4,5-Dihydro-Oxazole in Synthesis of N-Protected 2,3,4,6-Tetradeoxy-4-C-Methyl-4-Amino-L-Hexose Derivatives", J. Carbohydrate Chem., 10(2):197-213, 1991.
Fronza, G., et al., On the Use of (4S, 5S) 2 Phenyl 4, 5 Dimethyl 4 Formyl 4,5 Dihydro Oxazole in Synthesis of N Protected 2,3,4,6 Tetradeoxy 4 C Methyl 4 Amino L Hexose Derivatives , J. Carbohydrate Chem. , 10(2):197 213, 1991. *
Furukawa, J., et al., "3,4-Dihydroxy-2-Hydroxymethylpyrrolidine from Arachniodes Standishii ", Phytochemistry, 24(7):593-594, 1985.
Furukawa, J., et al., 3,4 Dihydroxy 2 Hydroxymethylpyrrolidine from Arachniodes Standishii , Phytochemistry , 24(7):593 594, 1985. *
Huang et al., J. Org. Chem., 62, 372 376, 1997. *
Huang et al., J. Org. Chem., 62, 372-376, 1997.
Lafargue et al., Synlett, 1995, 171 172. *
Lafargue et al., Synlett, 1995, 171-172.
Meyers et al., Synthesis, 1993, 2, 250 82. *
Meyers et al., Synthesis, 1993, 2, 250-82.
Morell et al., J. Org. Chem., 42(2), 355 356, 1977. *
Morell et al., J. Org. Chem., 42(2), 355-356, 1977.
Mori et al., Tetrahedron, 41(12), 2379 2386, 1985. *
Mori et al., Tetrahedron, 41(12), 2379-2386, 1985.
Nash, R.J., et al., "2-Hydroxymethyl-3,4-Dihydroxypyrrolidine in Fruits of Angylocalyx Boutiqueanus " Phytochemistry, 24(7):1620-1622, 1985.
Nash, R.J., et al., 2 Hydroxymethyl 3,4 Dihydroxypyrrolidine in Fruits of Angylocalyx Boutiqueanus Phytochemistry , 24(7):1620 1622, 1985. *
Pearson, W.H., et al., "A Practical Synthesis of (-)-Swainsonine", J. Org. Chem., 61:7217-7221, 1996.
Pearson, W.H., et al., A Practical Synthesis of ( ) Swainsonine , J. Org. Chem. , 61:7217 7221, 1996. *
Pfister, 3rd, et al, J. Am. Chem. Soc., 71, 1101 1105, 1949. *
Pfister, 3rd, et al, J. Am. Chem. Soc., 71, 1101-1105, 1949.
Provencher, L., et al., "Five-Membered ring Azasugars as Potent Inhibitors of α-L-Rhamnosidase (Naringinase) from Penicillium decumbens", Bioorgan. & Medic. Chem., 2(11):1179-1188 1994.
Provencher, L., et al., Five Membered ring Azasugars as Potent Inhibitors of L Rhamnosidase (Naringinase) from Penicillium decumbens , Bioorgan. & Medic. Chem. , 2(11):1179 1188 1994. *
Robinson, K.M., et al., "Intestinal disaccharidase inhibitors", Drugs of the Future, 17(8):705-720, 1992.
Robinson, K.M., et al., Intestinal disaccharidase inhibitors , Drugs of the Future , 17(8):705 720, 1992. *
Seebach et al., Tetrahedron Lett., 24(32), 3311 3314, 1983. *
Seebach et al., Tetrahedron Lett., 24(32), 3311-3314, 1983.
Tkaczuk et al., J. Org. Chem., 46, 4393 4398, 1981. *
Tkaczuk et al., J. Org. Chem., 46, 4393-4398, 1981.
Wipf et al., Tetrahedron Lett., 33(7), 907 910, 1992. *
Wipf et al., Tetrahedron Lett., 33(7), 907-910, 1992.

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518437B1 (en) * 2000-08-02 2003-02-11 Board Of Trustees Of Michigan State University Process and intermediate compounds for the preparation of pyrrolidines
EP1305284A1 (en) * 2000-08-02 2003-05-02 Michigan State University Process and intermediate compounds for the preparation of pyrrolidines
EP1305284A4 (en) * 2000-08-02 2005-08-03 Univ Michigan State Process and intermediate compounds for the preparation of pyrrolidines
US20100298538A1 (en) * 2007-11-19 2010-11-25 Bcn Péptides, S.A. Method for the stereoselective preparation of amino acid derivatives
US8791294B2 (en) * 2007-11-19 2014-07-29 Bcn Peptides, S.A. Method for the stereoselective preparation of amino acid derivatives

Also Published As

Publication number Publication date
WO1999046243A1 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
US5126494A (en) Methods for catalytic asymmetric dihydroxylation of olefins
Kasahara et al. Asymmetric total synthesis of (+)-negamycin and (-)-3-epinegamycin via enantioselective 1, 3-dipolar cycloaddition
FR2786768A1 (en) 2-AMINO-BICYCLO (3.1.O) 2,6-DICARBOXYLIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION
US5621142A (en) Aminoalkylcyclopropane derivatives
Hosokawa et al. Palladium (II)-catalyzed asymmetric acetalization of alkenes
Romeyke et al. Secondary metabolites by chemical screening-13. Enantioselective synthesis of δ-lactones from streptenola, achiral building block from streptomyces
EP2218722B1 (en) Process for producing benzoxazine derivative and production intermediate thereof
Imaizumi et al. Highly Potent Chiral Labeling Reagents for the Discrimination of Chiral Alcohols∗
HUT68255A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
Giordano et al. Direct conversion of (1S, 2S)-2-amino-1-[(4-methylthio) phenyl]-1, 3-propanediol into its enantiomer for efficient synthesis of thiamphenicol and florfenicol
US5801247A (en) Process for the enantioselective synthesis of hydroxypyrrolidines from amino acids and products thereof
Graziani et al. An improved procedure for the enantioselective synthesis of (+)-and (−)-cis-4-hydroxyprolines and bulgecinines
JPH10245369A (en) Production of serine derivative
JP2834501B2 (en) Production method and intermediate of 3,4-epoxybutyrate
Kazmaier et al. A short synthesis of polyhydroxylated piperidines by aldol reaction of chelated amino acid ester enolates
JP4661272B2 (en) Process for producing chiral 4-methyl-4-[(arylcarbooxy) ethyl] -oxetan-2-one and chiral mevalonolactone
JP3724854B2 (en) Process for producing 1-azabicyclo [1.1.0] butane
JP3050104B2 (en) Novel method for producing 1-butyne-3,4-diol
CA1273932A (en) Process for production of dihydropyridine compound or salts thereof
JP4524845B2 (en) Method for producing optically active allyl alcohol derivative having amino group, and optically active compound
US5959141A (en) 1-amino-2-hydroxycycloalkanecarboxylic acid derivatives
JP3060915B2 (en) trans-3-hydroxy-4-phenylthiotetrahydrofuran and process for producing the same
Elliott et al. Synthesis and absolute configuration of (R)-and (S)-ethyl 3-(4-oxocyclohex-2-enyl) propionate
AU772225B2 (en) Production method of optically active transvinylsulfide alcohol
JP4135258B2 (en) NOVEL COMPOUND, PROCESS FOR PRODUCING THE SAME AND INTERMEDIATE

Legal Events

Date Code Title Description
AS Assignment

Owner name: TEMPLE, UNIVERSITY OF, COMMONWEALTH SYSTEM OF, THE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DALTON, DAVID R.;HUANG, YIFANG;REEL/FRAME:008491/0913;SIGNING DATES FROM 19970403 TO 19970406

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060901